DT‐02‐05: MARKVCID PHASE II: PRIORITIZED CANDIDATE SMALL VESSEL VCID BIOMARKERS SELECTED FOR INDEPENDENT MULTI‐SITE TESTING AND VALIDATION. (1st July 2006) - Corriveau, Roderick A.